Maya Ibelaidene, Rachna Subramony
A 45 year old male with a past medical history of gastric sleeve presented to the Emergency Department with two days of progressively worsening right upper quadrant (RUQ) abdominal pain. The pain was constant, dull in character, and radiated intermittently to the back. It was associated with nausea, vomiting, fever, chills, but no chest pain, or changes in bowel habits. He denied prior similar episodes, alcohol misuse, or known gallstone disease. There was no history of liver disease.
Vital Signs: BP 130/83 mmHg | HR 56 | T 98.7°F | RR 18 | SpO₂ 100% on room air
The patient appeared uncomfortable but was not in acute distress. Cardiopulmonary examination was unremarkable. Abdominal examination revealed focal tenderness in the RUQ with a positive Murphy’s sign. There was no rebound, guarding, or palpable mass. No scleral icterus was noted.
Laboratory studies demonstrated elevated liver enzymes with a cholestatic pattern: AST 186 U/L, ALT 501 U/L, alkaline phosphatase 512 U/L, and total bilirubin 6.2 mg/dL (direct predominance).
Given the patient’s RUQ pain and abnormal liver function tests, a point of care ultrasound (POCUS) of the RUQ was performed at the bedside to evaluate for biliary pathology. Examination was conducted using a low-frequency (2–5 MHz) curvilinear transducer. The gallbladder was assessed in longitudinal and transverse planes.

The gallbladder appeared significantly enlarged, consistent with biliary obstruction. Multiple echogenic foci with posterior acoustic shadowing were noted within the lumen.
Despite careful scanning, the common bile duct (CBD) was difficult to visualize clearly at the bedside. Attempts were made in multiple planes and patient positions; however, bowel gas and patient body habitus limited optimal delineation of the duct. No obvious intrahepatic biliary ductal dilation was confidently identified on POCUS.
Given laboratory evidence of cholestasis and a distended gallbladder concerning for distal obstruction, formal radiology performed ultrasound was obtained, demonstrating dilation of the CBD measuring 9 mm with an obstructing distal stone consistent with choledocholithiasis.
Subsequent magnetic resonance cholangiopancreatography (MRCP) confirmed the presence of a CBD stone. The patient underwent endoscopic retrograde cholangiopancreatography (ERCP) with successful stone extraction and clinical improvement.
Discussion
Choledocholithiasis, defined as the presence of gallstones within the CBD, commonly presents with right upper quadrant pain, jaundice, and cholestatic liver enzyme abnormalities, and may progress to acute cholangitis or gallstone pancreatitis if untreated. POCUS is highly sensitive for detecting cholelithiasis and sonographic features of acute cholecystitis, but direct visualization of the CBD can be technically challenging in the emergency setting.
Bedside ultrasound reliably detects gallstones, gallbladder wall thickening, pericholecystic fluid, and a sonographic Murphy’s sign. In contrast, evaluation of the CBD requires deliberate technique and careful anatomic identification.
The duct is best located by first identifying the portal triad within the hepatoduodenal ligament. In a transverse view at the porta hepatis, the portal vein appears as the largest circular structure with echogenic walls. The CBD is typically positioned anterolateral to the portal vein, while the hepatic artery lies anteromedial forming the classic “Mickey Mouse sign,” which helps distinguish the CBD from adjacent vascular structures (Figure 2).

Color Doppler should be used to confirm that the suspected structure is nonvascular, as the CBD should not demonstrate internal flow (Figure 3). Optimal probe placement in the right upper quadrant along the midclavicular line with slight cephalad angulation, combined with rotation between longitudinal and transverse planes, improves visualization. Sliding medially toward the epigastrium and employing deep inspiration or left lateral decubitus positioning may further enhance acoustic windows. When visualized, the CBD should be measured inner wall to inner wall in the transverse plane, with diameters greater than 6 mm generally considered dilated in adults, though this threshold increases with age and prior cholecystectomy. Tracing the duct distally toward the pancreatic head may reveal obstruction, although distal visualization is frequently limited by bowel gas.

Despite optimization strategies, POCUS has inherent limitations. Bowel gas, body habitus, and operator experience significantly affect image quality, and CBD stones are often not directly visualized. Instead, obstruction may be inferred through indirect findings such as intrahepatic biliary dilation or a markedly distended gallbladder. A case report by Herbst demonstrated POCUS identification of a dilated CBD in a patient with suspected choledocholithiasis, which subsequently normalized on repeat imaging after presumed spontaneous stone passage, underscoring both the dynamic nature of biliary obstruction and the value of serial assessment.¹ Systematic evaluations indicate that while ultrasound reliably identifies CBD dilation, its sensitivity for detecting CBD stones is significantly lower, which necessitates adjunctive imaging for definitive diagnosis.² More recent evidence supports integrating POCUS findings with clinical and laboratory data to improve diagnostic accuracy and expedite management in suspected choledocholithiasis.³
Given these limitations and evidence, confirmatory imaging such as comprehensive abdominal ultrasound, MRCP or ERCP is often required for definitive diagnosis and therapeutic planning.
In this case, the markedly enlarged gallbladder combined with cholestatic laboratory abnormalities heightened suspicion for distal biliary obstruction. Although the CBD was not clearly visualized on POCUS even with such a dilated gallbladder and later formal imaging revealing dilated CBD, the recognition of indirect sonographic findings appropriately prompted further imaging and facilitated timely intervention.
Conclusion
This case highlights both the utility and limitations of POCUS in the evaluation of suspected choledocholithiasis. While POCUS excels in the rapid identification of cholelithiasis and secondary signs of biliary obstruction, direct visualization of CBD stones remains challenging and operator dependent. Recognition of indirect findings such as gallbladder distention, intrahepatic ductal dilation, and supportive laboratory abnormalities plays a critical role in raising suspicion for distal obstruction.
Current literature supports the integration of serial POCUS examinations with clinical assessment and laboratory data to enhance diagnostic accuracy and guide timely management. However, due to its limited sensitivity for detecting CBD stones directly, confirmatory imaging with formal ultrasound, MRCP, or ERCP is often required.
Ultimately, this case underscores the importance of a multimodal diagnostic approach. When used thoughtfully, POCUS serves as a valuable first line tool that can expedite recognition of biliary obstruction, prompt appropriate additional imaging, and facilitate timely intervention, thereby improving patient outcomes in the emergency setting.
References
- Herbst et al. Point-of-care ultrasound identification of transient common bile duct dilation due to choledocholithiasis. J Emerg Med. 2021. PMID: 33339646.
- Meta-analysis assessing the diagnostic performance of ultrasound for CBD stones and dilation. Clin Imaging. 2014. PMID: 24126067.
- Recent evaluation of POCUS utility in suspected choledocholithiasis and clinical decision support. Ultrasound Med Biol. 2022. PMID: 34995366.

















